Executive Director/Vice President Global Media Relations
BridgeBio
Executive Director/Vice President Global Media Relations
BridgeBio
Develops therapies for genetic diseases
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
This is a global role. Demonstrated international communications experience is required — candidates must have led media and corporate communications outside the United States, across multiple markets and regulatory regimes. Experience confined to the U.S. market will not meet the bar for this position.
We are seeking a seasoned, globally experienced communications leader to run our communications function and own how our story reaches the world. As VP, Global Media Relations & Corporate Communications, you will serve as our principal media strategist and spokesperson partner — setting one coherent corporate narrative and adapting it across every market in which we operate. You should bring established, durable relationships with the journalists who cover our science and our sector on both sides of the Atlantic and beyond, and preparing our executives to represent the company with clarity and credibility anywhere in the world.
This role sits at the intersection of media, markets, and science. You will lead media communications around clinical data readouts, regulatory milestones, earnings, and business development announcements — U.S. and international alike — working shoulder-to-shoulder with Investor Relations, Commercial, Legal, Government & Medical Affairs, and Regulatory. You will be equally comfortable driving proactive storytelling during moments of momentum or scrutiny.
You will develop a dynamic and growing team, supported by US and Global Communications leads.
Responsibilities
Within the brand & comms team you will:
Lead Global Communications
Build BridgeBio’s corporate and executive visibility
Serve as Strategic Counsel to Executives and Spokespeople
Corporate Reputation & International Operations
Where You'll Work
Based in Palo Alto, but a global role. Regular international travel is required for media engagements, scientific congresses, investor conferences, and time with regional teams and agency partners. Flexibility to work across time zones is expected.
Who You Are
Required experience:
Additional qualifications:
Preferred Background
International and global experience:
Other preferred qualifications:
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For BridgeBio Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
By applying, you acknowledge that BridgeBio will process your personal information as described in ourGlobal Candidate Privacy Notice.
Salary 275000 - 345000 USD
BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.
Explore more opportunities at BridgeBio